Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance, Molecular Cancer Therapeutics, vol.8, issue.8, pp.2086-95, 2009. ,
DOI : 10.1158/1535-7163.MCT-09-0366
Thermodynamics of calmodulin and tubulin binding to the vinca-alkaloid vinorelbine, Molecular Biology, vol.45, issue.4, pp.697-702, 2011. ,
DOI : 10.1134/S0026893311040108
Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours, British Journal of Cancer, vol.82, issue.1, pp.142-50, 2000. ,
DOI : 10.1054/bjoc.1999.0891
Increased expression and differential phosphorylation of stathmin may promote prostate cancer progression. The Prostate. 1 juill, pp.1038-52, 2007. ,
The Phosphoprotein Op18/Stathmin is Differentially Expressed in Ovarian Cancer, Cancer Investigation, vol.7, issue.8, pp.722-752, 2000. ,
DOI : 10.1016/S0968-0004(96)80013-2
The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancer, British Journal of Cancer, vol.5, issue.6, pp.1180-1187, 2014. ,
DOI : 10.1021/pr100712t
Reversal of Stathmin-Mediated Resistance to Paclitaxel and Vinblastine in Human Breast Carcinoma Cells, Molecular Pharmacology, vol.71, issue.5, pp.1233-1273, 2007. ,
DOI : 10.1124/mol.106.029702
Taxol and anti-stathmin therapy: a synergistic combination that targets the mitotic spindle, Cancer Res. 1 juill, vol.60, issue.13, pp.3537-3578, 2000. ,
Elevated levels of microtubule destabilizing factors in a Taxol-resistant/dependent A549 cell line with an alpha-tubulin mutation, Cancer Res. 15 mars, vol.63, issue.6, pp.1207-1220, 2003. ,
Synergistic Antiangiogenic Effects of Stathmin Inhibition and Taxol Exposure, Molecular Cancer Research, vol.5, issue.8, pp.773-82, 2007. ,
DOI : 10.1158/1541-7786.MCR-06-0290
The oncoprotein 18/stathmin family of microtubule destabilizers, Current Opinion in Cell Biology, vol.14, issue.1, pp.18-24, 2002. ,
DOI : 10.1016/S0955-0674(01)00289-7
Stathmin Strongly Increases the Minus End Catastrophe Frequency and Induces Rapid Treadmilling of Bovine Brain Microtubules at Steady State in Vitro, Journal of Biological Chemistry, vol.281, issue.4, pp.2071-2079, 2006. ,
DOI : 10.1074/jbc.M510661200
Stathmin/Op18 is a novel mediator of vinblastine activity, FEBS Letters, vol.46, issue.17, p.18588888, 2008. ,
DOI : 10.1016/j.febslet.2008.06.035
Microtubule-Associated Proteins and Tubulin Interaction by Isothermal Titration Calorimetry, Methods Cell Biol, vol.115, pp.283-302, 2013. ,
DOI : 10.1016/B978-0-12-407757-7.00018-9
URL : https://hal.archives-ouvertes.fr/hal-01478645
New insights into tau???microtubules interaction revealed by isothermal titration calorimetry, Biochimie, vol.94, issue.3, pp.916-925, 2012. ,
DOI : 10.1016/j.biochi.2011.09.011
Deciphering the molecular mechanisms of anti-tubulin plant derived drugs, Phytochemistry Reviews, vol.37, issue.19, pp.157-69, 2014. ,
DOI : 10.1007/s11101-013-9302-8
URL : https://hal.archives-ouvertes.fr/hal-01470519
Antitumor Activity of Vinflunine: Effector Pathways and Potential for Synergies, Seminars in Oncology, vol.35, issue.3, p.18538174, 2008. ,
DOI : 10.1053/j.seminoncol.2008.01.011
Thermodynamics of the Op18/Stathmin-Tubulin Interaction, Journal of Biological Chemistry, vol.278, issue.40, pp.38926-38960, 2003. ,
DOI : 10.1074/jbc.M305546200
Mechanism for the catastrophe-promoting activity of the microtubule destabilizer Op18/stathmin, Proceedings of the National Academy of Sciences, vol.110, issue.51, pp.20449-54, 2013. ,
DOI : 10.1073/pnas.1309958110
Exploring the Mechanisms of Action of the Novel Microtubule Inhibitor Vinflunine, Seminars in Oncology, vol.35, issue.3, pp.6-12, 2008. ,
DOI : 10.1053/j.seminoncol.2008.01.009
Energetics of vinca alkaloid interactions with tubulin, Methods Enzymol, vol.323, pp.77-103, 2000. ,
DOI : 10.1016/S0076-6879(00)23362-4
Structural basis for the regulation of tubulin by vinblastine, Nature, vol.60, issue.7041, pp.519-541, 2005. ,
DOI : 10.1038/nature02197
Oncoprotein 18 overexpression increases the sensitivity to vindesine in the human lung carcinoma cells, Cancer, vol.27, issue.8, pp.1494-1503, 2001. ,
DOI : 10.1002/1097-0142(20010415)91:8<1494::AID-CNCR1157>3.0.CO;2-7
The mechanism of action of Na glutamate, lysine HCl, and piperazine-N,N'- bis(2-ethanesulfonic acid) in the stabilization of tubulin and microtubule formation, J Biol Chem. 25 avr, vol.259, issue.8, pp.4979-86, 1984. ,
Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer, Cancer Res. 1 déc, vol.62, issue.23, pp.6864-6873, 2002. ,
Stathmin Protein Level, a Potential Predictive Marker for Taxane Treatment Response in Endometrial Cancer, PLoS ONE, vol.25, issue.2, p.24587245 ,
DOI : 10.1371/journal.pone.0090141.t001
Op18/Stathmin Is Involved in the Resistance of Taxol Among Different Epithelial Carcinoma Cell Lines, Cancer Biotherapy & Radiopharmaceuticals, vol.29, issue.9, pp.376-86, 2014. ,
DOI : 10.1089/cbr.2014.1649
Silencing stathmin-modulating efficiency of chemotherapy for esophageal squamous cell cancer with paclitaxel, Cancer Gene Therapy, vol.32, issue.3, 2015. ,
DOI : 10.3109/00365521.2012.683042
Control of Intrinsically Disordered Stathmin by Multisite Phosphorylation, Journal of Biological Chemistry, vol.281, issue.23, pp.16078-83, 2006. ,
DOI : 10.1074/jbc.M513524200
Regulation of Microtubule Dynamic Instability in Vitro by Differentially Phosphorylated Stathmin, M900343200 PMID, pp.15640-15649, 2009. ,
DOI : 10.1074/jbc.M900343200
Stathmin and its Phosphoprotein Family. General Properties, Biochemical and Functional Interaction with Tubulin., Cell Structure and Function, vol.24, issue.5, pp.345-57, 1999. ,
DOI : 10.1247/csf.24.345